Literature DB >> 32141921

Toward Causally Interpretable Meta-analysis: Transporting Inferences from Multiple Randomized Trials to a New Target Population.

Issa J Dahabreh1,2,3, Lucia C Petito4, Sarah E Robertson1, Miguel A Hernán3,5,6, Jon A Steingrimsson7.   

Abstract

We take steps toward causally interpretable meta-analysis by describing methods for transporting causal inferences from a collection of randomized trials to a new target population, one trial at a time and pooling all trials. We discuss identifiability conditions for average treatment effects in the target population and provide identification results. We show that the assumptions that allow inferences to be transported from all trials in the collection to the same target population have implications for the law underlying the observed data. We propose average treatment effect estimators that rely on different working models and provide code for their implementation in statistical software. We discuss how to use the data to examine whether transported inferences are homogeneous across the collection of trials, sketch approaches for sensitivity analysis to violations of the identifiability conditions, and describe extensions to address nonadherence in the trials. Last, we illustrate the proposed methods using data from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial.

Entities:  

Mesh:

Year:  2020        PMID: 32141921      PMCID: PMC9066547          DOI: 10.1097/EDE.0000000000001177

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.860


  30 in total

1.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.

Authors:  I Giatras; J Lau; A S Levey
Journal:  Ann Intern Med       Date:  1997-09-01       Impact factor: 25.391

3.  Extending inferences from a randomized trial to a target population.

Authors:  Issa J Dahabreh; Miguel A Hernán
Journal:  Eur J Epidemiol       Date:  2019-06-19       Impact factor: 8.082

4.  Some statistical methods for combining experimental results.

Authors:  N M Laird; F Mosteller
Journal:  Int J Technol Assess Health Care       Date:  1990       Impact factor: 2.188

5.  Albuminuria and racial disparities in the risk for ESRD.

Authors:  William M McClellan; David G Warnock; Suzanne Judd; Paul Muntner; Reshma Kewalramani; Mary Cushman; Leslie A McClure; Britt B Newsome; George Howard
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

6.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

7.  Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.

Authors:  Christopher H Schmid; Paul C Stark; Jesse A Berlin; Paul Landais; Joseph Lau
Journal:  J Clin Epidemiol       Date:  2004-07       Impact factor: 6.437

8.  Extending inferences from a randomized trial to a new target population.

Authors:  Issa J Dahabreh; Sarah E Robertson; Jon A Steingrimsson; Elizabeth A Stuart; Miguel A Hernán
Journal:  Stat Med       Date:  2020-04-06       Impact factor: 2.373

9.  Study Designs for Extending Causal Inferences From a Randomized Trial to a Target Population.

Authors:  Issa J Dahabreh; Sebastien J-P A Haneuse; James M Robins; Sarah E Robertson; Ashley L Buchanan; Elizabeth A Stuart; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

10.  A re-evaluation of random-effects meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson; David J Spiegelhalter
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2009-01       Impact factor: 2.483

View more
  7 in total

Review 1.  Methods to Address Confounding and Other Biases in Meta-Analyses: Review and Recommendations.

Authors:  Maya B Mathur; Tyler J VanderWeele
Journal:  Annu Rev Public Health       Date:  2021-09-17       Impact factor: 21.981

2.  Precision medicine in cardiorenal and metabolic diseases with routinely collected clinical data: a novel insight.

Authors:  Sheyu Li; Qingyang Shi; Valentyn Litvin; Charles F Manski
Journal:  Precis Clin Med       Date:  2022-09-24

3.  Causally Interpretable Meta-analysis: Application in Adolescent HIV Prevention.

Authors:  David H Barker; Issa J Dahabreh; Jon A Steingrimsson; Christopher Houck; Geri Donenberg; Ralph DiClemente; Larry K Brown
Journal:  Prev Sci       Date:  2021-07-09

4.  A survey of methodologies on causal inference methods in meta-analyses of randomized controlled trials.

Authors:  Georgios Markozannes; Georgia Vourli; Evangelia Ntzani
Journal:  Syst Rev       Date:  2021-06-09

5.  Toward Causally Interpretable Meta-analysis: Transporting Inferences from Multiple Randomized Trials to a New Target Population.

Authors:  Issa J Dahabreh; Lucia C Petito; Sarah E Robertson; Miguel A Hernán; Jon A Steingrimsson
Journal:  Epidemiology       Date:  2020-05       Impact factor: 4.860

Review 6.  Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19.

Authors:  Xabier García-Albéniz; Julia Del Amo; Rosa Polo; José Miguel Morales-Asencio; Miguel A Hernán
Journal:  Eur J Epidemiol       Date:  2022-08-09       Impact factor: 12.434

7.  Rejoinder: Learning Optimal Distributionally Robust Individualized Treatment Rules.

Authors:  Weibin Mo; Zhengling Qi; Yufeng Liu
Journal:  J Am Stat Assoc       Date:  2021-04-01       Impact factor: 5.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.